Lactose in tablets: Functionality, critical material attributes, applications, modifications and co-processed excipients.
co-processed excipient
critical material attributes
critical quality attributes
lactose
modification
quality by design
tablet
Journal
Drug discovery today
ISSN: 1878-5832
Titre abrégé: Drug Discov Today
Pays: England
ID NLM: 9604391
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
01
02
2023
revised:
06
06
2023
accepted:
29
06
2023
medline:
4
9
2023
pubmed:
8
7
2023
entrez:
7
7
2023
Statut:
ppublish
Résumé
Lactose is one of the most widespread excipients used in the pharmaceutical industry. Because of its water solubility and acceptable flowability, lactose is generally added into tablet formulation to improve wettability and undesirable flowability. Based on Quality by Design, a better understanding of the critical material attributes (CMAs) of raw materials is beneficial in guiding the improvement of tablet quality and the development of lactose. Additionally, the modifications and co-processing of lactose can introduce more-desirable characteristics to the resulting particles. This review focuses on the functionality, CMAs, applications, modifications and co-processing of lactose in tablets.
Identifiants
pubmed: 37419210
pii: S1359-6446(23)00212-X
doi: 10.1016/j.drudis.2023.103696
pii:
doi:
Substances chimiques
Excipients
0
Lactose
J2B2A4N98G
Tablets
0
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
103696Informations de copyright
Copyright © 2023 Elsevier Ltd. All rights reserved.